SILK
K993999 · Trading Consultants and Distributors Intl., Inc. · GAP · Feb 4, 2000 · General, Plastic Surgery
Device Facts
| Record ID | K993999 |
| Device Name | SILK |
| Applicant | Trading Consultants and Distributors Intl., Inc. |
| Product Code | GAP · General, Plastic Surgery |
| Decision Date | Feb 4, 2000 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.5030 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
SILK is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic and neurological procedures.
Device Story
SILK is a sterile, nonabsorbable, flexible multifilament surgical suture composed of fibroin protein derived from Bombyx mori. Offered as braided or twisted, uncoated or silicon-coated, and undyed or dyed with FDA-listed colorants (D&C Blue No. 9 or Logwood extract). Used by surgeons for soft tissue approximation and ligation in cardiovascular, ophthalmic, and neurological procedures. Device provides mechanical support to tissues during healing; tensile strength gradually decreases in vivo due to proteinaceous fiber degradation. Supplied sterile for single use, with or without attached surgical needles.
Clinical Evidence
No clinical data provided. Substantial equivalence established via non-clinical bench testing demonstrating conformance to U.S.P. standards for nonabsorbable surgical sutures, including physical properties and functionality testing.
Technological Characteristics
Material: Fibroin (Bombyx mori). Form: Braided/twisted multifilament. Coating: Uncoated or silicon. Sterilization: Gamma irradiation. Standards: U.S.P. monograph for nonabsorbable surgical sutures, ISO 9002, EN 46002, EN 552. Packaging: Aluminum foil and polyester.
Indications for Use
Indicated for general soft tissue approximation and/or ligation, including cardiovascular, ophthalmic, and neurological procedures. Prescription use only.
Regulatory Classification
Identification
Natural nonabsorbable silk surgical suture is a nonabsorbable, sterile, flexible multifilament thread composed of an organic protein called fibroin. This protein is derived from the domesticated species Bombyx mori (B. mori ) of the family Bombycidae. Natural nonabsorbable silk surgical suture is indicated for use in soft tissue approximation. Natural nonabsorbable silk surgical suture meets the United States Pharmacopeia (U.S.P.) monograph requirements for Nonabsorbable Surgical Suture (class I). Natural nonabsorbable silk surgical suture may be braided or twisted; it may be provided uncoated or coated; and it may be undyed or dyed with an FDA listed color additive.
Special Controls
*Classification.* Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.
Predicate Devices
- Silk Non-Absorbable Surgical Sutures of Davis & Geck (K930590)
Related Devices
- K024091 — SILK SUTURES · Aurolab · Feb 28, 2003
- K990089 — SILKAM NONABSORBABLE SILK SURGICAL SUTURE · Aesculap, Inc. · Mar 15, 1999
- K960328 — SILK NONABSORBABLE SURGICAL SUTURES USP · R. K. Medical L. L. C. · Mar 4, 1996
- K982853 — SILK SUTURE · Davis & Geck, Inc. · Apr 30, 1999
- K041514 — TRUESILK NON-ABSORBABLE SILK SURGICAL SUTURE · Sutures India Private Limited · Jun 3, 2005
Submission Summary (Full Text)
{0}------------------------------------------------
T.CAD International 991002/MG-510(K) SILK
### SECTION III
# 510(K) Summary of Safety and Effectiveness
This summary of safety and effectiveness information is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and Title 21 CFR §807.92
### A. Applicant & Submitted By:
| Trading Consultants And Distributors International Inc. | |
|---------------------------------------------------------|---------------------------|
| (T.CAD International) | |
| 157 WindDance Dr. | |
| Chicago, IL 60046-6681 | |
| Telephone: (847) 265-7676 | |
| Fax.: (847) 265-7686 | |
| Contact Person: | Main M. Ghazal, President |
| Date Prepared: | October 2nd 1999. |
### B. Device Name:
- Trade Name: SILK a.
- Common or Usual Name: Silk Surgical Suture, Nonabsorbable ﻓ
- c. Classification Name: Natural nonabsorbable silk surgical suture (Per 21CFR878.5030)
#### C. Predicate Device:
Silk Non-Absorbable Surgical Sutures of Davis & Geck (K930590)
### D. Device Description:
SILK is a nonabsorbable, sterile, flexible multifilament thread composed of an organic protein called fibroin. This protein is derived from the domesticated species Bombyx mori (B. mori) of the family Bombycidae.
SILK is offered braided, uncoated or silicon coated, undyed or dyed with an FDA listed color additive, D&C Blue No. 9 (21CFR74.1109), or Logwood extract, C.I. Natural Black 1 (21CFR74.1410). SILK meets the United States Pharmacopeia (U.S.P.) monograph requirements for nonabsorbable silk surgical sutures.
### E. Intended Use:
SILK is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic and neurological procedures.
{1}------------------------------------------------
493999
T.CAD International
991002/MG-510(k)
SILK
| | SILK | Predicate Device |
|----------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | General soft tissue approximation<br>and/or ligation, including use in<br>cardiovascular, ophthalmic and<br>neurological procedures. | General soft tissue approximation<br>and/or ligation, including use in<br>cardiovascular, ophthalmic and<br>neurological procedures. |
| Suture Material | Natural Organic Protein (Fibroin).<br>Braided or Twisted, available in<br>White (Virgin) or Dyed (Black or<br>Blue). | Natural Organic Protein (Fibroin).<br>Braided or Twisted, available in<br>White (Virgin) or Dyed (Black or<br>Blue). |
| Suture<br>Characteristics | Not absorbed, progressive<br>degradation of the proteinaceous<br>silk fiber <i>in vivo</i> may result in<br>gradual loss of all of the suture's<br>tensile strength over time. | Not absorbed, progressive<br>degradation of the proteinaceous<br>silk fiber <i>in vivo</i> may result in<br>gradual loss of all of the suture's<br>tensile strength over time. |
| Sterilization Method | Gamma Irradiation | Same of equivalent process |
| How Supplied | Sterile and offered for Single Use<br>Only. Braided, uncoated or coated,<br>undyed or dyed with an FDA<br>listed color additive. Available<br>with or without surgical needle.<br>Meet U.S.P. Requirements | Same or equivalent manner.<br>Predicate device is offered<br>braided, coated with silicon,<br>undyed or dyed with the same<br>FDA listed colorants.<br>Meet U.S.P. Requirements |
| Suture Diameter,<br>Suture Length,<br>Knot Pull Tensile<br>Strength and Needle<br>Attachment<br>Strength | | |
| Packaging | Dry packaged in Aluminum Foil<br>and Polyester tear open packaging. | Dry packaged in Tyvek/Mylar |
| Labeling | In conformance with CDRH<br>instructions of the "Medical<br>Device Quality Manual" dated<br>December 1996. Package Inserts<br>in accordance with the FDA<br>Guidance documents "Alternate<br>Suture Labeling" Resulting from<br>the January 11th 1993 meeting with<br>HIMA, reformatted on December<br>17th 1997. | Same. |
### F. Comparison to Predicate Device:
{2}------------------------------------------------
K943999
T.CAD International 991002/MG-510(k) SILK
#### G. Clinical & Non-Clinical Testing:
Non-Clinical Testing was conducted on the subject device to prove conformance to the requirements of U.S.P. standards and to demonstrate substantial equivalence to the predicate device. Physical properties and functionality testing assured the safety and effectiveness of the subject device within its intended uses. Results of the non-clinical testing demonstrate conformance with the U.S.P. standards and requirements for Absorbable surgical suture.
Clinical Testing: Not available at the present time.
#### H. Conclusion:
Based on the detailed device description, the intended use of the device, the technological characteristics and physical properties of the device, performance testing and conformance with voluntary performance standards like:
- a. United States Pharmacopeia Standards
- b. ISO 9002, EN 46002 & EN 552 Standards
- c. FDA Guidance documents "Alternate Suture Labeling" Resulting from the January 11th 1993 meeting with HIMA.
T.CAD International believes that the subject device demonstrates a substantial equivalence to the predicate device.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
FEB 4 2000
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Main M. Ghazal Trading Consultants and Distributors International, Inc. 157 WindDance Drive Chicago, Illinois 60046-6681
Re: K993999 Trade Name: Silk Regulatory Class: II Product Code: GAP Dated: November 22, 1999 Received: November 24, 1999
Dear Mr. Ghazal:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent for the indications for use stated in the enclosure, to devices that were regulated as transitional devices and that have been reclassified into class II. Notice of this reclassification was published in the Federal Register on Tuesday, October 26, 1993 (Vol. 58, No. 205, Pages 57557 and 57558). A copy of this Federal Register can be obtained by calling the Division of Small Manufacturers Assistance (DSMA) at (800) 638-2041 or (301) 443-6597. You may, therefore, market the device, subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act) and the following limitations:
- 1. The Silk is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic and neurological procedures.
- 2. This device may not be manufactured from any material other than multifilamentous fibers composed of fibroin, an organic protein that is derived from the domesticated species Bombyx mori (B. mori) of the family Bombycidae. In addition, you must maintain documentation at your premises regarding vendor certification for raw or semiprocessed source material, all manufacturing and quality control release procedures, and validation of sterilization procedures used in the manufacture of the Silk. Any deviation of the source material or processing as described in this 510(k) notification requires submission of a new premarket notification and Food and Drug Administration (FDA) clearance prior to commercial distribution of the modified device.
The sale, distribution and use of this device are restricted to prescription use in accordance with 21 CFR 801.109.
{4}------------------------------------------------
Page 2 - Mr. Main M. Ghazal
The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practices, labeling, and prohibition against misbranding and adulteration.
Existing major regulations affecting your device can be found in the Code of Federal Regulations (CFR). Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practices (GMP) for Medical Devices: General GMP regulation (21 CFR Part 820) and that, through periodic GMP inspections, The Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control Provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4595. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or 301-443-6597, or at its internet address http://www.fda.gov/cdrh/dsmamain.html.
Sincerely yours,
Neil R.P. Ogden
James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
{5}------------------------------------------------
# K993999
T.CAD International 991002/MG-510(k) SILK
### SECTION II
## Statement of indication for use
Device Name: SILK
510(k) Number:
Indication for use: SILK is indicated for use in general soft tissue approximation and /or ligation, including use in cardiovascular, ophthalmic and neurological procedures.
(PLEASE DO NOT WRITE BELOW THE LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21CFR 801.109)
OR Over-the-Counter Use
NRO for J20
(Division Sign-Off) Division of General Restorative De--- ----------------------------------------------------------------------------------------------------------------------------------------